Tranexamic acid is a synthetic derivative of [lysine] used as an antifibrinolytic in the treatment and prevention of major bleeding. It possesses a similar mechanism of action to aminocaproic acid but is approximately 10-fold more potent. It was first patented in 1957 and received its initial US approval in 1986. It is grouped under the following drug class(es): Amino Acids. Its therapeutic use is listed as dermatologicals and hematologic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Amcha, Lysteda and Rikavarin. Its PubChem CID is 5526.
Tranexamic acid
| CAS No | 1197-18-8 |
|---|---|
| Molecular Formula | C8H15NO2 |
| Molecular Weight | 157.21 g/mol |
| Synonyms | trans-4-(Aminomethyl)cyclohexanecarboxylic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Tranexamic acid is a synthetic derivative of [lysine] used as an antifibrinolytic in the treatment and prevention of major bleeding. It possesses a similar mechanism of action to aminocaproic acid but is approximately 10-fold more potent.
The listed CAS number is 1197-18-8.
The listed molecular formula is C8H15NO2.
The listed molecular weight is 157.21 g/mol.
trans-4-(Aminomethyl)cyclohexanecarboxylic acid.
The source lists Amcha, Lysteda and Rikavarin.